HPV typing in Brazilian patients with epidermodysplasia verruciformis: High prevalence of EV-HPV 25

Journal of Cutaneous Medicine and Surgery

Volumn 8, Issue 2, 2004, Pages 110-115

  De Oliveira, Walmar Roncalli P ^a,b   He, Qin ^b   Rady, Peter L ^b   Hughes, Thomas K ^b   Neto, Cyro Festa ^a   Rivitti, Evandro A ^a   Tyring, Stephen K ^b,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b University of Texas Medical Branch School of Medicine   (United States)

^c University of Texas Health Science Center at Houston   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAZIL; CLINICAL ARTICLE; COMPUTER ANALYSIS; EPIDERMODYSPLASIA VERRUCIFORMIS; FEMALE; HUMAN; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN BIOPSY; VERRUCA VULGARIS; VIRUS CARCINOGENESIS; VIRUS TYPING; WART VIRUS;

EID: 2942637464     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1177/120347540400800206     Document Type: Article

References (37)

1. Majewski S, Jablonska S. Epidermodysplasia verruciformis. In: Sterling JC, Tyring SK, eds. Human papillomaviruses clinical and scientific advances. New York: Oxford University Press, 2001, pp 90-101.
2. Jablonska S, Majewski S. Epidermodysplasia verruciformis: Immunological and clinical aspects. Curr Top Microbiol Immunol 1994; 186:157-175.
3. de Oliveira WRP, Festa Neto C, Rady PL, et al. Clinical aspects of epidermodysplasia verruciformis. J Eur Acad Dermatol Venereol 2003; 17:394-398.
4. Majewski S, Jablonska S. Do epidermodysplasia verruciformis human papillomaviruses contribute to malignant and benign epidermal proliferations? Arch Dermatol 2002; 138:629-654.
5. Ramoz N, Rueda LA, Bouadjar B, et al. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 2002; 32:579-581.
6. Majewski S, Jablonska S. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancers: The role of local immunosurveillance. Am J Med Sci 1992; 304:174-179.
7. Majewski S, Jablonska S. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch Dermatol 1995; 131:1312-1318.
8. Majewski S, Jablonska S. Immunology of HPV infection and HPV-associated tumors. Int J Dermatol 1998; 37:81-95.
9. Lutzner MA, Blanchet-Bardon C, Orth G. Clinical observations, virologic studies, and treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific human papillomaviruses. J Invest Dermatol 1984; 83:18s-25s.
10. Oliveira WR, Festa C, Rady PL, et al. Seborrheic keratosis-like lesions in patients with epidermosdysplasia verruciformis. J Dermatol 2003; 30:48-53.
11. Tomasini C, Aloi F, Pippione M. Seborrheic keratosis-like lesions in epidermodysplasia verruciformis. J Cutan Pathol 1993; 20:237-241.
12. Jacyk WK, Dreyer L, Villiers EM. Seborrheic keratosis of black patients with epidermodysplasia verruciformis contains human papillomavirus DNA. Am J Dermatopathol 1993; 15:1-6.
13. Cobb MW. Human papillomavirus infection. J Am Acad Dermatol 1990; 22:547-566.
14. Majewski S, Jablonska S. Human papillomavirus-associated tumors of the skin and mucosa. J Am Acad Dermatol 1997; 36:659-685.
15. Orth G. Epidermodysplasia verruciformis. In: Saezman PH, Howley PH, eds The Papovaviridae, Vol. 2, The Papillomaviruses. New York: Plenum Press, 1987, p 199.
16. Jacyk WK, de Villiers EM. Epidermodysplasia verruciformis in Africans. Int J Dermatol 1993; 32:806-810.
17. Kanda R, Tanigaki T, Kitano Y, et al. Types of human papillomavirus isolated from Japanese with epidermodysplasia verruciformis. Br J Dermatol 1989; 121:463-469.
18. De Villiers EM. Papillomavirus and HPV typing. Clin Dermatol 1997; 5:199-206.
19. Androphy EJ. Molecular biology of human papillomavirus infection and oncogenesis. J Invest Dermatol 1994; 103:248-256.
20. Zur Hausen H. Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta 1996; 1288:F55-F78.
21. Favre M, Ramoz N, Orth G. Human papillomavirus: general features. Clin Dermatol 1997; 15:181-189.
22. Mansur C. Molecular mechanisms of HPV associated oncogenesis. In: Sterling JC, Tyring SK, eds. Human papillomaviruses clinical and scientific advances. New York: Oxford University Press, 2001, pp 24-37.
23. Tieben-de Jong IM, Berkhout RJM, Smiths HL, et al. Detection of epidermodysplasia verruciformis-like human papillomavirus types in malignant and pre-malignant lesions of renal transplant recipients. Br J Dermatol 1994; 131:226-230.
24. Höpfl R, Bens G, Wieland UW, et al. Human papillomavirus DNA in non-melanoma skin cancers of a renal transplant recipient: Detection of a new sequence related to epidermodysplasia verruciformis associated types. J Invest Dermatol 1997; 108:53-56.
25. Kawashima M, Favre M, Obalek S, et al. Premalignant lesions and cancers of the skin in the general population: evaluation of the role of human papillomavirus. J Invest Dermatol 1990; 95:537-542.
26. Boxmann ILA, Berkhout RJM, Mulder LHC, et al. Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol 1997; 108:712-715.
27. Chan SY, Delius H, Halpern AL, et al. Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny and taxonomy. J Virol 1995; 69:3074-3083.
28. Berkhout RJ, Tieben LM, Smiths HL, et al. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol 1995; 33:690-695.
29. Doorbar J, Sterling JC. The biology of human papillomavirus. In: Sterling JC, Tyring SK, eds Human papillomaviruses clinical and scientific advances. New York: Oxford University Press, 2001, pp 10-23.
30. Harwood CA, Spink PJ, Surentheran T, et al. Degenerate and nested PCR: a high sensitive and specific method for detection of human papillomavirus infection in cutaneous warts. J Clin Microbiol 1999; 37:3545-3555.
31. Shuman S. Novel approach to molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase. J Biol Chem 1994; 269:32678-32684.
32. Orth G, Jablonska S, Favre M, et al. Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformis. Proc Natl Acad Sci USA 1978; 75:1537-1541s.
33. Orth G, Jablonska S, Jarzabek-Chorzelska M, et al. Epidermodysplasia verruciformis: characteristic of the lesions and risk of malignant conversion as related to the type of human papillomavirus lesions. Cancer Res 1979; 39:1074-1082.
34. Deau MC, Favre M, Orth G. Genetic heterogeneity among papillomaviruses (HPV) associated with epidermodysplasia verruciformis: evidence for multiple allelic forms of HPV 5 and HPV 8 E6 genes. Virology 1991; 184:492-503.
35. Ostrow RS, Bender M, Niimura M, et al. Human papillomavirus DNA in cutaneous primary and metastasized squamous cell carcinomas from patients with epidermodysplasia verruciformis. Proc Natl Acad Sci USA 1982; 79:1634-1638.
36. Rubaie AS, Breuer J, Inshasi J, et al. Epidermodysplasia with neurological manifestations. Int J Dermatol 1998; 37:766-771.
37. Orth G. Epidermodysplasia verruciformis: a model for understanding the oncogenicity of human papillomaviruses. Ciba Foundation Symposium 120, Papillomaviruses. Chichester: Wiley, 1986, pp 157-174.